Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5891

A pancreatic cancer approval; Seres cuts staff

$
0
0
Plus, news about Nxera: 🟢 FDA approves Novocure’s pancreatic cancer device: Known as Optune Pax, it employs electric “tumor treating fields" that disrupt cancer cell division. It’s the first treatment to win

Viewing all articles
Browse latest Browse all 5891

Trending Articles